DEF: Xcel Brands Sets Annual Meeting, Seeks Equity Plan Expansion

Sentiment:

Proxy Statement 17 October 2025 4:23 PM

Xcel Brands, Inc. announced its 2025 Annual Meeting of Stockholders to be held on December 3, 2025, where key proposals include the election of five directors, an increase in shares for its equity incentive plan, and the ratification of a new independent accounting firm.

Delay expectedThe company was unable to file its Annual Report on Form 10-K and Quarterly Report on Form 10-Q within the time specified by SEC rules and forms.The delay was caused by a material weakness in entity-level controls impacting Information and Communication and Monitoring, specifically due to dependence on a third party for financial information from an unconsolidated affiliate.

Capital raiseA public offering of 328,427 shares of common stock at $6.50 per share was completed on March 19, 2024.A private placement of 29,462 shares at $9.80 per share occurred concurrently on March 14, 2024, with participation from CEO Robert W. DLoren, Director Mark DiSanto, and EVP Seth Burroughs.In December 2024, the company refinanced its term loan debt, which included a $250,000 advance from IPX Capital, LLC (controlled by CEO Robert W. DLoren) to a subsidiary, with $200,000 repaid upon closing.IPX Capital, LLC also purchased a $500,000 subordinated participation interest in a portion of the new term loan debt in December 2024, and a $500,000 subordinated participation interest in Term Loan A on April 21, 2025.

Worse than expectedNet income for 2024 was -$22,395,000, indicating a deeper loss compared to -$21,052,000 in 2023.Total Shareholder Return (TSR) for 2024 was -$60.08, a significant negative return, which is a substantial deterioration from the positive $84.29 in 2023.The company disclosed a material weakness in internal controls over financial reporting, leading to the dismissal of its independent auditor and delayed SEC filings, which is a severe negative indicator for financial health and governance.

Summary

The 2025 Annual Meeting of Stockholders will be held on Wednesday, December 3, 2025, at 11:00 A.M. (local time) at the company's New York offices.
Stockholders will vote on the election of five directors, the amendment and restatement of the 2021 Equity Incentive Plan to increase reserved shares from 400,000 to 1,150,000, and the ratification of Wolf & Company, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The Board of Directors unanimously recommends a vote FOR all proposed matters.
The record date for stockholders entitled to vote at the Annual Meeting is October 8, 2025.
Net income for the fiscal year ended December 31, 2024, was -$22,395,000, a worsening from -$21,052,000 in 2023.
Total Shareholder Return (TSR) for 2024 was -$60.08, a significant decline from $84.29 in 2023.
CEO Robert W. DLoren's total compensation for 2024 was $936,256, down from $1,078,121 in 2023.
CFO James F. Haran's total compensation for 2024 was $366,769, down from $374,857 in 2023.
EVP Seth Burroughs' total compensation for 2024 was $340,600, down from $348,531 in 2023.
From July 16, 2024, to December 31, 2025, 40% of the base salaries for CEO Robert W. DLoren and EVP Seth Burroughs are being paid in shares of the company's common stock.
The company dismissed CBIZ CPAs as its independent registered public accounting firm on September 15, 2025, due to a material weakness in internal controls that prevented timely SEC filings.
Related party transactions include equity transfers in IM Topco, services and license agreements with IM Topco, executive purchases in a public offering and private placement, debt refinancing participation by IPX Capital (controlled by the CEO), and a personal guarantee by the CEO for a real estate lease.

Sentiment

Score: 3

Explanation: The filing outlines necessary corporate governance actions and attempts to strengthen employee incentives. However, the negative financial performance (increased net loss, negative TSR) and the disclosure of a material weakness in internal controls leading to auditor dismissal and delayed filings indicate significant operational and financial challenges. The reliance on stock-based salary payments for executives and related-party debt financing also suggests potential liquidity concerns.

Positives

The Board of Directors unanimously recommends all proposals, indicating internal alignment on key corporate actions.
The proposed increase in the 2021 Equity Incentive Plan shares aims to attract and retain high-caliber employees, directors, and consultants, which is crucial for future growth and profitability.
The company is actively addressing its auditor situation by appointing a new firm, Wolf & Company, PC, to ensure compliance and proper financial oversight.
The company has established a Code of Ethics and an Insider Trading Policy to promote ethical conduct and compliance with federal securities laws.

Negatives

Net income for 2024 was -$22,395,000, representing a worsening financial performance compared to -$21,052,000 in 2023.
Total Shareholder Return (TSR) for 2024 was -$60.08, a significant negative return, contrasting sharply with the positive $84.29 in 2023.
A material weakness in internal controls was identified, specifically impacting Information and Communication and Monitoring, which led to the inability to file Annual Report on Form 10-K and Quarterly Report on Form 10-Q within SEC specified times.
The previous independent auditor, CBIZ CPAs, was dismissed due to the material weakness and did not issue an audit report, raising concerns about financial reporting reliability.
The decision for CEO Robert W. DLoren and EVP Seth Burroughs to accept 40% of their base salary in common stock from July 16, 2024, to December 31, 2025, could indicate cash flow constraints or a strategic move to conserve cash.
CEO Robert W. DLoren and Seth Burroughs were late in reporting four Section 16(a) transactions, indicating potential compliance lapses.

Risks

A material weakness in internal controls over financial reporting, specifically related to Information and Communication and Monitoring, and dependence on a third party for financial information from an unconsolidated affiliate, poses a risk to accurate and timely financial reporting.
The company's ability to attract and retain high-caliber employees, directors, and consultants is dependent on a competitive equity incentive program, and failure to do so could hinder growth.
Potential for adverse tax consequences under Section 409A of the Code if equity awards are not structured and administered in compliance with regulations.
Related party transactions, such as the CEO's personal guarantee for a lease and IPX Capital's participation in debt refinancing, could present conflicts of interest or raise questions about independent decision-making.
The company's compensation policies and practices, while reviewed for risk, may still carry inherent risks that could lead to excessive risk-taking if not adequately managed.

Future Outlook

The Board believes that increasing the shares available under the 2021 Equity Incentive Plan is essential to attract and retain high-caliber employees, directors, and consultants, and to motivate them to enhance growth and profitability as the company grows. The company aims to operate effectively in recruitment and create incentives for retention through these equity arrangements.

Management Comments

"Our 2024 results are presented in our Annual Report."
"Your vote is very important. Whether or not you plan to attend the meeting in person, we will appreciate a prompt submission of your vote. We hope to see you at the meeting."
"The Xcel Brands, Inc. Board of Directors believes that the election of the nominees specified in the accompanying proxy statement as directors at the Annual Meeting is in the best interest of the Company and its stockholders and, accordingly, unanimously recommends a vote FOR such nominees."
"Furthermore, the Board of Directors unanimously recommends that you vote FOR the proposal to increase the number shares under the Companys equity plan from 400,000 shares to 1,150,000 shares, and FOR the proposal to ratify the appointment of Wolf & Company, PC as the Companys independent registered public accounting firm."
"The Board believes that a single person, acting in the capacities of Chairman and Chief Executive Officer, provides unified leadership and focus."
"The Compensation Committee believes that, for all of our employees, including our named executive officers, our compensation programs do not lead to excessive risk-taking and instead encourage behavior that supports sustainable value creation."
"We believe that risks that may arise from our compensation policies and practices for our employees, including our named executive officers, are not reasonably likely to have a material adverse effect on our Company."

Industry Context

The company operates in the consumer branded products industry, emphasizing an omni-channel platform that integrates digital, brick-and-mortar, social media, and direct-response television. Its investment in ORME, a short-form video and social commerce marketplace, reflects an adaptation to evolving retail and marketing trends, particularly in digital and social commerce. The company's focus on licensing and brand management aligns with a broader industry trend of intellectual property monetization and brand extension strategies.

Comparison to Industry Standards

The filing does not provide specific comparisons to industry benchmarks or named competitors regarding financial performance or operational metrics.
It mentions that the company reviews compensation levels of "companies that we deem to be similar to our Company regardless of their location" to attract and retain executives, but no specific comparable companies or results are listed.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Board Composition	The Board consists of five members, with four out of five (Messrs. DiSanto, Fielding, Liebman, and Ms. Weinswig) determined to be independent under NASDAQ listing rules.	N/A	Maintains a majority of independent directors, which is generally viewed positively for oversight, despite the CEO also serving as Chairman.
Leadership Structure	The Chief Executive Officer also serves as the Chairman of the Board, providing unified leadership and focus.	N/A	The Board believes this structure enhances the CEO's ability to provide insight and direction. Independent board committees and executive sessions without the CEO are intended to ensure independent oversight.
Committee Structure	The Board has three standing committees (Audit, Compensation, Nominating), all comprised solely of independent directors and operating under written charters.	N/A	Ensures independent oversight of critical areas like financial reporting, executive compensation, and director nominations.
Audit Committee Financial Expert	Mr. Howard Liebman has been determined to meet the requirements to serve as the Audit Committee Financial Expert.	N/A	Provides specialized financial expertise to the Audit Committee, enhancing its ability to oversee financial reporting and internal controls.
Equity Incentive Plan	Proposal to amend and restate the 2021 Equity Incentive Plan to increase the number of shares reserved from 400,000 to 1,150,000.	Upon stockholder approval	Aims to enhance the company's ability to attract and retain key talent through competitive equity awards, but could lead to shareholder dilution.
Auditor Appointment	Ratification of Wolf & Company, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, following the dismissal of CBIZ CPAs.	Upon stockholder ratification	Crucial for restoring confidence in financial reporting after a material weakness and auditor change. Stockholder ratification reinforces auditor independence.
Compliance Reporting	CEO Robert W. DLoren and EVP Seth Burroughs were late in reporting four Section 16(a) transactions.	N/A	Indicates minor compliance lapses by key executives, which could raise concerns about internal controls and adherence to regulatory requirements.
Code of Ethics and Insider Trading Policy	The company has adopted a Code of Ethics applicable to officers, employees, and directors, and an Insider Trading Policy with special restrictions for directors and executive officers.	N/A	Establishes clear guidelines for ethical conduct and compliance with securities laws, aiming to prevent conflicts of interest and insider trading.

Related Party Transactions

Xcel transferred 12.5% equity interests in IM Topco, LLC to WHP Global on April 15, 2025, and agreed to transfer its remaining 17.5% equity interests to IMWHP2 on October 1, 2025, as part of a settlement agreement.
Xcel provides design and support services to IM Topco, LLC for $150,000 per year (amended April 2024), with IM Topco prepaying $62,500 for 2025 services as of December 31, 2024.
Xcel guaranteed IM Topco, LLC for an estimated $325,000 royalty shortfall in 2023, and agreed to additional royalty payments totaling $450,000, of which $137,500 remained due as of December 31, 2024.
CEO Robert W. DLoren, an affiliate of Director Mark DiSanto, and EVP Seth Burroughs purchased shares in a March 2024 public offering at $6.50 per share and in a concurrent private placement at $9.80 per share.
IPX Capital, LLC, controlled by CEO Robert W. DLoren, made a $250,000 advance to a company subsidiary in December 2024, with $200,000 repaid, and purchased a $500,000 subordinated participation interest in the company's term loan debt.
On April 21, 2025, IPX Capital's participation in Term Loan B was repaid, and it purchased a $500,000 subordinated participation interest in Term Loan A.
CEO Robert W. DLoren, EVP Seth Burroughs, and Director Mark D. Santo entered into a Support Agreement on April 21, 2025, to vote in favor of warrant issuance proposals.
Xcel granted UTG Capital, Inc. (a significant shareholder) the right to nominate one individual to the Board, contingent on certain loan or warrant holding conditions.
CEO Robert W. DLoren provided a personal guarantee in October 2024 for a standby letter of credit related to the company's real estate lease.
The company acquired a noncontrolling equity interest in ORME for $150,000 in December 2023; ORME licenses technology from KonnectBio Inc., in which CEO Robert W. DLoren owns approximately 19%.

Stakeholder Impact

Shareholders: Will vote on significant corporate governance matters, including director elections and equity plan expansion. Experience negative financial performance and potential dilution from equity awards. Related party transactions may raise concerns about alignment of interests.
Employees: The proposed expansion of the equity incentive plan aims to attract and retain talent, potentially benefiting employees through increased opportunities for stock options and restricted stock.
Customers/Suppliers/Licensees: No direct impact is explicitly mentioned, but the company's financial health and strategic direction, including its brand management and licensing activities, could indirectly affect business relationships.
Creditors: The debt refinancing and participation by related parties (IPX Capital) are relevant to creditors, indicating ongoing financial management and potentially the need for additional capital.
Management: Executive compensation is tied to performance goals and includes equity awards. Executives are involved in related party transactions and hold significant ownership stakes, aligning their interests with company performance, but also raising potential conflict of interest considerations.

Next Steps

Hold the 2025 Annual Meeting of Stockholders on December 3, 2025, to vote on director elections, equity plan amendment, and auditor ratification.
Stockholders are encouraged to submit their votes promptly, either online, by telephone, or by mail.
The Audit Committee will review the company's relationship with Wolf & Company, PC if stockholders do not ratify their selection.
Stockholders wishing to present proposals for the 2026 Annual Meeting must submit a notice by June 16, 2026.

Key Dates

Date	Description
1985	Robert W. DLoren founded and served as President and CEO of the DLoren Organization.
1987	James F. Haran began his tenure at Sidney Yoskowitz and Company P.C.
1988	Mark DiSanto began serving as CEO of Triple Crown Corporation.
1994	Howard Liebman joined Shorewood Packaging Corporation as Executive Vice President and Chief Financial Officer.
1997	Robert W. DLoren founded and acted as President and Chief Operating Officer of CAK Universal Credit Corporation.
1998	James F. Haran became CFO and Chief Credit Officer for UCC Capital Corporation.
1999	Howard Liebman served as President of Shorewood Packaging Corporation.
2000	Shorewood Packaging Corporation was acquired by International Paper.
2001	Seth Burroughs worked as a Senior Financial Analyst at The Pullman Group.
2002	Robert W. DLoren became President and CEO of UCC Capital Corporation.
March 2002	Deborah Weinswig was employed by Citigroup, Inc.
2003	Seth Burroughs served as Director of M&A Advisory and Investor Relations at UCC Capital Corporation.
2005	Howard Liebman retired from Shorewood Packaging Corporation.
June 2006	Robert W. DLoren became a director, President and CEO of NexCen Brands, Inc.
June 2006	Seth Burroughs served as Vice President of NexCen Brands, Inc.
2007	Howard Liebman became President, COO, and director of Hobart West Group.
May 2008	James Fielding served as President of Disney Stores Worldwide.
June 2008	James F. Haran served as CFO of IPX Capital, LLC.
2009	Robert W. DLoren served as Chairman and CEO of IPX Capital, LLC.
September 2011	Robert W. DLoren became Chairman of the Board, CEO, and President of Xcel Brands, Inc.
September 2011	James F. Haran became Chief Financial Officer of Xcel Brands, Inc.
September 2011	Seth Burroughs became Executive Vice President of Business Development and Treasury of Xcel Brands, Inc.
October 2011	Mark DiSanto and Howard Liebman joined the Board of Xcel Brands, Inc.
2012	James Fielding ceased serving as President of Disney Stores Worldwide.
October 2013	Deborah Weinswig ceased employment with Citigroup, Inc.
April 2014	Deborah Weinswig became Managing Director of Funding Global Retail & Technology (FGRT).
January 2018	Deborah Weinswig was appointed to the Board of Xcel Brands, Inc.
July 2018	James Fielding was appointed to the Board of Xcel Brands, Inc.
January 1, 2019	Effective date of Robert W. DLoren's, James Haran's, and Seth Burroughs' employment agreements.
February 28, 2019	Date employment agreements were entered into for Robert W. DLoren, James Haran, and Seth Burroughs.
June 30, 2019	Guaranteed bonus payment for James Haran for 2019 was paid.
June 30, 2020	Guaranteed bonus payment for James Haran for 2020 was paid.
April 19, 2022	Effective date of the 2021 Equity Incentive Plan.
May 31, 2022	Company entered into a services agreement and a license agreement with IM Topco, LLC.
December 16, 2022	License agreement between IM Topco and Xcel was terminated.
July 1, 2023	Reduction of future service fees for IM Topco began.
November 2023	Services agreement with IM Topco was amended; Company, WHP, and IM Topco amended the May 2022 membership purchase agreement.
December 4, 2023	Company acquired a noncontrolling equity ownership interest in ORME.
December 31, 2023	End of fiscal year 2023; estimated shortfall of $325,000 in royalties from IM Topco.
March 14, 2024	Company entered into subscription agreements for private placement shares with Mr. DLoren, Mr. DiSanto, and Mr. Burroughs.
March 19, 2024	Public offering of 328,427 shares of common stock was consummated.
April 3, 2024	Non-employee directors granted 1,000 shares of restricted stock and options to purchase 2,500 shares of stock.
April 2024	Services agreement with IM Topco was further amended to set service fees at $150,000 per year.
July 16, 2024	Commencement date for 40% of CEO and EVP Burroughs' base salary to be paid in common stock.
July 30, 2024	Company entered into an amendment of the DLoren and Burroughs Employment Agreements.
October 2024	Mr. DLoren provided a personal guarantee for a standby letter of credit.
December 2024	Refinancing of the Company's term loan debt.
December 31, 2024	End of fiscal year 2024; remaining payments due to IM Topco totaled $137,500.
January 31, 2025	WHP Global became contractually entitled to receive 12.5% equity interests in IM Topco from Xcel.
February 28, 2029	Expiration date for executive stock options granted in 2019.
March 24, 2025	1-10 reverse stock split effected.
April 3, 2025	50% of restricted stock and options granted on April 3, 2024, will vest.
April 15, 2025	Equity interests in IM Topco transferred to WHP.
April 21, 2025	IPX's participation in Term Loan B was repaid, and IPX purchased a $500,000 participation interest in Term Loan A. Robert DLoren, Seth Burroughs, and Mark D. Santo entered into a Support Agreement. Xcel and UTG Capital, Inc. entered into a Board Nomination Agreement.
May 27, 2025	Marcum LLP was dismissed, and CBIZ CPAs was appointed, as the Company's independent registered public accounting firm.
May 28, 2025	Annual Report on Form 10-K for fiscal year ended December 31, 2024, was filed with the SEC.
September 1, 2032	End date for capital appreciation right related to IM Topco.
September 15, 2025	Audit Committee dismissed CBIZ CPAs as the Company's independent registered accounting firm.
September 16, 2025	Company informed CBIZ CPAs of its termination.
September 19, 2025	Current Report on Form 8-K filed regarding CBIZ CPAs dismissal.
September 26, 2025	Xcel, IM Topco, IMWHP, LLC, and IMWHP2 LLC entered into a Settlement Agreement.
October 1, 2025	Xcel agreed to transfer all its equity interests in IM Topco (17.5%) to IMWHP2.
October 8, 2025	Record Date for the 2025 Annual Meeting of Stockholders.
October 17, 2025	Date of Notice of Availability of Proxy Materials for the 2025 Annual Meeting of Stockholders.
December 2, 2025	Deadline for Internet voting (11:59 p.m., Eastern Time).
December 3, 2025	Date of the 2025 Annual Meeting of Stockholders.
December 31, 2025	End of fiscal year for which Wolf & Company, PC is appointed auditor; end date for 40% salary payment in stock for CEO and EVP Burroughs.
April 3, 2026	50% of restricted stock and options granted on April 3, 2024, will vest.
June 16, 2026	Deadline for stockholder proposals for the 2026 annual meeting to be included in the proxy statement.

Recommendation

sell

The company reported a worsening net loss and a significantly negative Total Shareholder Return for 2024. The disclosure of a material weakness in internal controls over financial reporting, leading to the dismissal of the previous auditor and delayed SEC filings, raises serious concerns about financial transparency and operational integrity. While the proposed equity plan expansion aims to retain talent, the overall financial performance and governance issues suggest a high level of risk and uncertainty, making the stock a 'sell' for a seasoned investor. The reliance on related-party financing and stock-based salary payments for executives further indicates potential underlying financial strain.

Keywords

Xcel Brands, Proxy Statement, Annual Meeting, Equity Incentive Plan, Corporate Governance, Director Election, Auditor Ratification, Executive Compensation, Related Party Transactions, Financial Reporting, Internal Controls, SEC Filing, NASDAQ, Brand Management, Retail, Licensing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.